Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Health Spending

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Critics Question Effectiveness Of Medicines Patent Pool In Improving Access To Drugs

SciDev.Net: Merck’s HIV patent agreement ignites monopoly criticism “Pharma giant Merck has become the latest drug company to share intellectual property rights with a U.N.-backed patent pool for HIV medicines, but critics have told SciDev.Net it is ‘a false solution to a real problem’…” (Kennedy, 3/16).

State Department Report Highlights PPPs, Work On Global Challenges

U.S. Department of State’s “DipNote”: What Global Challenges Could Best Be Addressed by Public-Private Partnerships? “The U.S. Department of State, USAID, and Concordia International hosted Global Partnerships Week, March 9-15, 2015. … The 2015 State of Global Partnerships Report released this week outlines a number of important public-private partnerships that…

Gates Foundation Using Direct Equity Investments To Further Its Goals

New York Times: From the Gates Foundation, Direct Investment, Not Just Grants “…The [Bill & Melinda Gates F]oundation, which has distributed billions of dollars in grants to improve health and living conditions in developing countries, is increasingly expanding its tool kit, using some of its capital to invest directly in…

Partnerships Vital To Creating ‘One Voice’ To Reach MNCH, FP/RH Goals

Devex: Fresh perspectives on maternal, child and adolescent health Robin Gorna, executive director for the Partnership for Maternal, Newborn & Child Health (PMNCH) “…PMNCH is such an exciting mechanism, bringing together all of the sectors involved in maternal, newborn, child, and adolescent health, and sexual and reproductive health and rights.…

Third Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part III In part three of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores China’s efforts to increase its market share of artemisinin-based combination therapies worldwide. “…To sum up, China has come…

USGLC Highlights Public-Private Partnership That Supports Refugees In South Sudan

U.S. Global Leadership Coalition: A Public-Private Partnership that’s Saving Refugees and Rescuing Aid Workers David Stein, policy associate at USGLC, marks Global Partnership Week and discusses how “forward-thinking businesses and nonprofits have been working with the U.S. government in innovative ways to tackle some of the toughest challenges in global…

Collaboration, Partnership Among Many Sectors Can Improve Health Access Worldwide

Huffington Post: Hurdling the Health Access Barrier Cassie Chandler, global manager of microfinance and health protection at Freedom from Hunger “…Whether in Asia, Latin America, or Africa, one of the most significant barriers to good health is being able to access health services in a timely manner. There are a…

Second Blog Post In Series Examines China’s History Of Artemisinin Drug Development

Council on Foreign Relation’s “Asia Unbound”: Artemisinin’s Rocky Road to Globalization: Part II In part two of his series on anti-malarial artemisinin drugs, Yanzhong Huang, CFR senior fellow for global health, explores the challenges China faced in marketing its artemisinin-based combination therapies worldwide. “…The 2004-2006 artemisinin bubble nevertheless has not…

U.S. Trade Policies Threaten To Undermine Successful Global Health Programs

The Hill: U.S. trade policy could raise drug prices, at home and abroad Rep. Jan Schakowsky (D-Ill.) and Peter Maybarduk, director of Public Citizen’s Global Access to Medicines program “…[With the creation of PEPFAR, t]he United States put public health needs ahead of pharmaceutical industry profits and made a transformative…